Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis

The CXC ligand (CXCL)12/CXC receptor (CXCR)4 chemokine–receptor axis controls hematopoiesis, organ development, and angiogenesis, but its role in the inflammatory pathogenesis of atherosclerosis is unknown. Here we show that interference with Cxcl12/Cxcr4 by a small-molecule antagonist, genetic Cxcr4 deficiency, or lentiviral transduction with Cxcr4 degrakine in bone marrow chimeras aggravated diet-induced atherosclerosis in apolipoprotein E-deficient (Apoe−/−) or LDL receptor–deficient (Ldlr−/−) mice. Chronic blockade of Cxcr4 caused leukocytosis and an expansion of neutrophils and increased neutrophil content in plaques, associated with apoptosis and a proinflammatory phenotype. Whereas circulating neutrophils were recruited to atherosclerotic lesions, depletion of neutrophils reduced plaque formation and prevented its exacerbation after blocking Cxcr4. Disrupting Cxcl12/Cxcr4 thus promotes lesion formation through deranged neutrophil homeostasis, indicating that Cxcl12/Cxcr4 controls the important contribution of neutrophils to atherogenesis in mice

[1]  A. Zernecke,et al.  Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice , 2007, Circulation.

[2]  J. Bernhagen,et al.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.

[3]  P. Libby,et al.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.

[4]  Christian Weber,et al.  Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[5]  K. Trinkaus,et al.  Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. , 2006, Blood.

[6]  John D Lambris,et al.  A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways1 , 2006, The Journal of Immunology.

[7]  D. Tregouet,et al.  Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis? , 2006, Atherosclerosis.

[8]  A. Zernecke,et al.  SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? , 2006, Trends in cardiovascular medicine.

[9]  C. Dunbar,et al.  AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. , 2006, Blood.

[10]  S. Sela,et al.  Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury. , 2006, American journal of physiology. Heart and circulatory physiology.

[11]  Fan Zhang,et al.  Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.

[12]  F. Ginhoux,et al.  Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery , 2006, The Journal of experimental medicine.

[13]  Rinat Abramovitch,et al.  VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells , 2006, Cell.

[14]  A. Gabrielsen,et al.  Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[15]  R. Storb,et al.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model. , 2005, Blood.

[16]  H. Miller,et al.  Transfer of Endothelial Progenitor and Bone Marrow Cells Influences Atherosclerotic Plaque Size and Composition in Apolipoprotein E Knockout Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[17]  I. Tabas.  Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Dominique Schols,et al.  AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. , 2005, Biochemical pharmacology.

[19]  J. Dipersio,et al.  The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. , 2005, Blood.

[20]  J. Seppen,et al.  persistent knockdown of CCR2 function in vivo Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to , 2013 .

[21]  G. Ailawadi,et al.  Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation , 2005, Circulation.

[22]  G. Kelsoe,et al.  Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow , 2005, The Journal of experimental medicine.

[23]  Christie M. Orschell,et al.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.

[24]  A. Zernecke,et al.  SDF-1&agr;/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells , 2005, Circulation research.

[25]  S. Todo,et al.  Stromal Cell–Derived Factor-1 and CXCR4 Interaction Is Critical for Development of Transplant Arteriosclerosis , 2004, Circulation.

[26]  A. Zernecke,et al.  Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[27]  I. Charo,et al.  Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.

[28]  K. Malcolm,et al.  Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. , 2004, Blood.

[29]  J. Kaski,et al.  Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. , 2004, Atherosclerosis.

[30]  B. Lévy,et al.  Transplantation of Bone Marrow–Derived Mononuclear Cells in Ischemic Apolipoprotein E–Knockout Mice Accelerates Atherosclerosis Without Altering Plaque Composition , 2003, Circulation.

[31]  A. Schober,et al.  Crucial Role of Stromal Cell–Derived Factor-1&agr; in Neointima Formation After Vascular Injury in Apolipoprotein E–Deficient Mice , 2003, Circulation.

[32]  L. Su,et al.  A genetic approach to inactivating chemokine receptors using a modified viral protein , 2003, Nature Biotechnology.

[33]  B. Wood,et al.  Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. , 2003, Blood.

[34]  S. Rankin,et al.  Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.

[35]  H. Broxmeyer,et al.  Transgenic Expression of Stromal Cell-Derived Factor-1/CXC Chemokine Ligand 12 Enhances Myeloid Progenitor Cell Survival/Antiapoptosis In Vitro in Response to Growth Factor Withdrawal and Enhances Myelopoiesis In Vivo , 2003, The Journal of Immunology.

[36]  Kazuo Haze,et al.  Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes , 2002, Circulation.

[37]  I. Petit,et al.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.

[38]  S. Frøland,et al.  Stromal Cell–Derived Factor-1&agr; in Unstable Angina: Potential Antiinflammatory and Matrix-Stabilizing Effects , 2002, Circulation.

[39]  Dominique Schols,et al.  AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. , 2002, The American journal of pathology.

[40]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[41]  E J Topol,et al.  Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.

[42]  P. Libby,et al.  The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. , 2000, Circulation research.

[43]  T. Graf,et al.  Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. , 2000, Blood.

[44]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[45]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[47]  R. Terkeltaub,et al.  A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.

[48]  J. Sasaki,et al.  Band neutrophil count and the presence and severity of coronary atherosclerosis. , 1996, American heart journal.

[49]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[50]  J. Mehta,et al.  Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. , 1990, Journal of the American College of Cardiology.

[51]  J. Kostis,et al.  Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. , 1984, The American journal of cardiology.